title: Minimally Invasive Pancreatic Resection: Is It Really the Future?
abstract: The introduction and widespread application of minimally invasive surgery has been one of the most important innovations that radically changed the practice of surgery during the last few decades. The application to pancreatic surgery of minimally invasive approach has only recently emerged: both laparoscopic distal pancreatectomy (LDP) and laparoscopic pancreaticoduodenectomy (LPD) can be competently performed. LDP and LPD are advocated to improved perioperative outcomes, including decreased blood loss, shorter length of stay, reduced postoperative pain and expedited time to functional recovery. However, the indication to minimally invasive approach for pancreatic surgery is often benign or low-grade malignant pathologies. In this review, we summarize the current data on minimally invasive pancreatic surgery, focusing on indication, perioperative and oncological outcomes.
authors.affiliation: Department of HBP Surgery, Edouard Herriot Hopsital, HCL and Lyon Faculty of Medicine, Lyon, France.
authors.forename: G
authors.initials: G
authors.lastname: Nappo
authors.forename: J
authors.initials: J
authors.lastname: Perinel
authors.forename: M
authors.initials: M
authors.lastname: El Bechwaty
authors.forename: M
authors.initials: M
authors.lastname: Adham
mesh_terms: D016063:Blood Loss, Surgical; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D007902:Length of Stay; D061646:Operative Time; D010180:Pancreatectomy / Q000379:methods* / Q000639:trends; D010182:Pancreatic Diseases / Q000601:surgery*; D016577:Pancreaticoduodenectomy / Q000379:methods* / Q000639:trends; D018579:Patient Selection